NASDAQ:NUWE

Nuwellis (NUWE) Stock Price, News & Analysis

$0.27
+0.02 (+6.98%)
(As of 09:39 AM ET)
Today's Range
$0.26
$0.30
50-Day Range
$0.25
$0.70
52-Week Range
$0.24
$5.73
Volume
3.74 million shs
Average Volume
992,259 shs
Market Capitalization
$1.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NUWE stock logo

About Nuwellis Stock (NASDAQ:NUWE)

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

NUWE Stock Price History

NUWE Stock News Headlines

Nuwellis (NASDAQ:NUWE) Shares Up 30%
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Maxim Group Keeps Their Buy Rating on Nuwellis (NUWE)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Q4 2023 Nuwellis Inc Earnings Call
Earnings Preview For Nuwellis
Nuwellis Q4 Earnings Preview
Nuwellis earnings: here's what to expect
Nuwellis Inc NUWE
Nuwellis Stock (NASDAQ:NUWE), Short Interest Report
Nuwellis, Inc. (22SA.F)
See More Headlines
Receive NUWE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/24/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NUWE
Fax
N/A
Employees
59
Year Founded
N/A

Profitability

Net Income
$-20,210,000.00
Net Margins
-227.99%
Pretax Margin
-227.90%

Debt

Sales & Book Value

Annual Sales
$8.86 million
Book Value
$0.53 per share

Miscellaneous

Free Float
6,741,000
Market Cap
$1.71 million
Optionable
Not Optionable
Beta
0.17
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Nestor Jaramillo Jr. (Age 67)
    President, CEO & Director
    Comp: $437.71k
  • Mr. Robert B. Scott (Age 44)
    Chief Financial Officer
    Comp: $252.6k
  • Mr. Neil P. Ayotte Esq. (Age 60)
    Senior VP, General Counsel, Secretary & Chief Compliance Officer
    Comp: $342.54k
  • Mr. John Kowalczyk
    Senior Vice President of Sales & Marketing
  • Ms. Sandra Eayrs
    Chief Human Resources Officer
  • Mr. Vitaliy Epshteyn (Age 46)
    Sr. Vice President of Operations & Engineering
  • Dr. John Lynn Jefferies FACC
    M.D., M.P.H., Chief Medical Officer & Member of Medical Advisory Board
  • Mr. Paul Wotta (Age 67)
    Corporate Controller

NUWE Stock Analysis - Frequently Asked Questions

Should I buy or sell Nuwellis stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nuwellis in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NUWE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUWE, but not buy additional shares or sell existing shares.
View NUWE analyst ratings
or view top-rated stocks.

How have NUWE shares performed in 2024?

Nuwellis' stock was trading at $0.5809 on January 1st, 2024. Since then, NUWE stock has decreased by 56.6% and is now trading at $0.2521.
View the best growth stocks for 2024 here
.

When is Nuwellis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our NUWE earnings forecast
.

How were Nuwellis' earnings last quarter?

Nuwellis, Inc. (NASDAQ:NUWE) announced its earnings results on Tuesday, March, 5th. The company reported ($2.24) earnings per share for the quarter, missing the consensus estimate of ($1.39) by $0.85. The firm had revenue of $2.55 million for the quarter. Nuwellis had a negative trailing twelve-month return on equity of 218.79% and a negative net margin of 227.99%. During the same period in the previous year, the company posted ($5.00) EPS.

When did Nuwellis' stock split?

Nuwellis shares reverse split on the morning of Sunday, December 11th 2022. The 1-100 reverse split was announced on Sunday, December 11th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of Nuwellis?

Shares of NUWE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUWE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners